Low/Intermediate PCa Video Chat, Nov 25, 2024

by | Nov 26, 2024 | Active Surveillance PCa, Cancer Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa

Low/Intermediate PCa Video Chat, Nov 25, 2024

Low/Intermediate PCa Video Chat, Nov 25, 2024

Ancan would like your input on its future planning and academic research. Please take a few minutes to complete The 2024 AnCan Survey which is at this link. 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Focal therapy delays the time for more definitive treatment options. (bj)

Topics Discussed

Long-term treatment options for post radiation urinary issues; learn the importance of getting a second opinion on a prostate biopsy – active surveillance may be an option. Getting a Decipher test — testing to determine the liklihood of cancer spreading; Prostate Cancer Research Institute (PCRI) is a valuable information source; Additional tests to screen for prostate cancer, such as: EpiSwitch PSE and ExoDx Prostate Test; Considering focal treatment options with a cribriform pattern and intraductal indications — High-Dose (HDR) Brachytherapy, High Intensity Focal Ultrasound (HIFU) and Tulsa-PRO; Prostox DNA testing to determine risk for Genitourinary (GU) toxicity.

Chat Log

AnCan  – rick
unauthorized!!!

Tim in Tampa
I completed the survey yesterday!

AnCan  – rick
Tx Tim….

AnCan  – rick
Ming Zhou https://profiles.mountsinai.org/ming-zhou

AnCan  – rick
JH 2nd opinion https://pathology.jhu.edu/patient-care/second-opinions

Causley
Boykin is the star.  He is the guru with this matter.